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Objective: The purpose of this study was to investigate the efficacy of temporin A as a prophylactic agent in a rat model of
vascular graft infection from methicillin sodium–susceptible and methicillin sodium–resistant Staphylococcus epidermidis.
Methods: The prospective, randomized, controlled animal study set in a research laboratory in a university hospital used
280 adult male Wistar rats (weight range, 280 to 350 g). Graft infections were established in the back subcutaneous tissue
of rats with implantation of 1-cm2 sterile Dacron grafts followed by topical inoculation with 2  107 colony-forming
units of S epidermidis. The study for each staphylococcal strain included: one control group (no graft contamination), one
contaminated group that did not receive any antibiotic prophylaxis, one contaminated group that received temporin
A–soaked graft, two contaminated groups that received perioperative intraperitoneal cefazolin (30 mg/kg) or vancomy-
cin hydrochloride prophylaxis (10 mg/kg), and two contaminated groups that received temporin A–soaked graft and
perioperative intraperitoneal cefazolin (30 mg/kg) or vancomycin hydrochloride (10 mg/kg) prophylaxis. All grafts were
explanted at 7 days after implantation. The main outcome measure was quantification of bacterial contamination.
Results: Overall, the perioperative prophylaxis based on soaked grafts was not significantly different to that of parenteral
vancomycin hydrochloride. Only the combination between temporin A and vancomycin hydrochloride produced a
complete bacterial inhibition for both strains.
Conclusion: Temporin A showed a similar antibacterial in vitro activity against the two different strains. The in vivo
results suggest its potential use in providing prophylaxis to direct graft contamination when used in combination with
parenteral vancomycin hydrochloride. (J Vasc Surg 2002;36:1027-30.)
Staphylococci are among the most common pathogens
that cause biomaterial infections. The patient can have late-
appearing signs of infection develop as commonly as early
postoperative infection, frequently resulting in prolonged
hospitalization, organ failure, amputation, and death.1,2 Vas-
cular prosthetic graft infection is one of the most feared
complications that the vascular surgeon treats, and Staphylo-
coccus epidermidis, a skin commensal, is well known to be the
most frequent cause of vascular graft infection in humans.3,4
The mainstay of prophylaxis is the perioperative administra-
tion of systemic antibiotics. Since the emergence of methicillin
sodium–resistant (MR) staphylococci, several protocols for
the prevention of prosthetic infection have been introduced in
different devices. For vascular grafts, antimicrobials bound in
high concentrations to prosthetic grafts have been proposed as
adjunctive prophylaxis.5-9
In recent years, several polycationic antimicrobial pep-
tides, compounds that play an important role in innate immu-
nity, have been isolated from bacteria, plants, insects, fish,
amphibians, birds, mammals, and humans.10 Particularly, am-
phibian skin has proven to be an especially rich source of
peptides. Several molecules from amphibian species have been
analyzed in detail and found to have antimicrobial activity
against a broad spectrum of bacteria.11-13 Among these mol-
ecules, temporins, a group of peptides isolated from the skin of
the European red frog Rana temporaria, showed activity
against clinically important gram-positive cocci, including MR
staphylococci and vancomycin hydrochloride–resistant En-
terococcus faecium. They are all amidated at the C-terminus;
those containing one basic residue, either lysine or arginine, in
the sequence (net charge2) were found to be active specif-
ically against gram-positive bacteria and Candida albicans.
They are among the smallest antimicrobial peptides.14-16
Temporin A is a basic, highly hydrophobic, antimicrobial
peptide amide (FLPLIGRVLSGIL-NH2) that has variable
antibiotic activity against a broad spectrum of microorgan-
isms. Like the other temporins, it is active against clinically
important antibiotic–resistant gram-positive cocci. Currently,
the following different hypotheses concern the mechanism of
action by which temporins kill organisms: inserting into the
hydrophobic core of the cell membrane, interaction with
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anionic heads and hydrocarbon tails of bacterial phospholip-
ids, binding to DNA, or altering enzyme activities.17,18 In this
study, we investigated the efficacy of temporin A as a prophy-
lactic agent in a rat model of vascular graft methicillin sodium–
susceptible (MS) and MR S epidermidis infection.
MATERIALS AND METHODS
Organisms. The commercially available quality con-
trol strain of MS S epidermidis ATCC 12228 (Oxoid SPA,
Milan, Italy) and one clinical isolate of MR S epidermidis
(Se15-00) were used.
Synthetic peptides. Temporin A was synthesized
manually with the solid phase method with the Fmoc/But
procedure (Faculty of Pharmacy, Medical University of
Gdan´sk, Poland) and was purified with reversed-phase (Vy-
dac C-18; 10 250 mm) high-pressure liquid chromatog-
raphy on a Knauer K501 two-pump system (Berlin, Ger-
many). The product was analyzed with high-pressure liquid
chromatography, chemical analysis, and matrix-assisted la-
ser-desorption ionization mass spectrometry. Temporin A
was dissolved in distilled H2O at 20 times the required
maximal concentration. Successively, serial dilutions of the
peptide were prepared in 0.01% acetic acid containing 0.2%
bovine serum albumin in polypropylene tubes.
Drugs. Cefazolin, vancomycin hydrochloride and ox-
acillin sodium were obtained from Sigma-Aldrich S.r.l.
(Milan, Italy). Powders were dissolved in accordance with
manufacturers’ recommendations. Solutions were made
fresh on the day of assay or stored at80° C in the dark for
short periods. The concentration range assayed for each
antibiotic was 0.25 to 256 g/mL.
Susceptibility testing. The antimicrobial susceptibili-
ties of the strains were determined with the microbroth dilu-
tion method, according to the procedures outlined by the
National Committee for Clinical Laboratory Standards.19
The minimum inhibitory concentration (MIC) was taken as
the lowest antibiotic concentration at which observable
growth was inhibited. However, the MIC of temporin A was
determined according to the procedures recently proposed for
testing antimicrobial peptides.20 Particularly, because cationic
peptides bind polystyrene, polypropylene 96-well plates (Sig-
ma-Aldrich) were substituted for polystyrene plates and incu-
bated for 18 hours at 37° C in air. Plates were shaken through-
out the study. Experiments were performed in triplicate.
Rat model. Adult male Wistar rats (weight range, 280
to 350 g) were studied. Graft infections were established in
the back subcutaneous tissue of rats with implantation of
1-cm2 sterile Dacron grafts (Saluggi VC, Italy) followed by
topical inoculation with 2  107 colony-forming units
(CFUs) of S epidermidis. The study for each staphylococcal
strain included: one control group with no graft contamina-
tion and no antibiotic prophylaxis (uncontaminated control;
C0), one contaminated group that did not receive any antibi-
otic prophylaxis (treated control; C1), one contaminated
group that received temporin A–soaked graft (TT); two con-
taminated groups that received perioperative intraperitoneal
30 mg/kg cefazolin (TC) or 10 mg/kg vancomycin hydro-
chloride (TV) prophylaxis, and two contaminated groups that
received temporin A–soaked graft and perioperative intraperi-
toneal 30 mg/kg cefazolin (TT-C) or 10 mg/kg vancomycin
hydrochloride (TT-V) prophylaxis. Each group was formed by
20 animals. Rats underwent anesthesia with ether, the hair of
the back was shaved, and the skin was cleaned with 10%
povidone-iodine solution. The groups TC, TV, TT-C, and
TT-V received intraperitoneal antibiotic prophylaxis 10 min-
utes before the surgical procedure. One subcutaneous pocket
was made on each side of the median line with a 1.5-cm
incision. Aseptically, 1-cm2 sterile collagen-sealed Dacron
grafts (Albograft, Sorin Biomedica Cardio, S.p.A., Saluggi
VC, Italy) were implanted into each pocket. Before implanta-
tion, the Dacron graft segments were impregnated with 10-
g/mL temporin A (groups TT, TT-C, and TT-V). Bonding of
the peptide was obtained immediately before implantation
with soaking grafts for 20 minutes in a sterile solution of the
compound. The pockets were closed with skin clips, and
sterile saline solution (1 mL) containing S epidermidis ATCC
12228 or the Se15-00 strain at a concentration of 2  107
CFU/mL was inoculated onto the graft surface with a tuber-
culin syringe to create a subcutaneous fluid-filled pocket.21
The animals were returned to individual cages and thoroughly
examined daily. All grafts were explanted at 7 days after
implantation.
Assessment of the infection. The explanted grafts
were placed in sterile tubes, washed in sterile saline solu-
tion, placed in tubes containing 10 mL of phosphate-
buffered saline solution, and sonicated for 5 minutes to
remove the adherent bacteria from the grafts. Quantifica-
tion of viable bacteria was performed with culturing serial
10-fold dilutions (0.1 mL) of the bacterial suspensions on
blood agar plates. All plates were incubated at 37° C for 48
hours and evaluated for the presence of the staphylococcal
strains. The organisms were quantified with counting the
number of CFUs per plate. The limit of detection for this
method was approximately 10 CFU/mL.
Statistical analysis. MIC values were presented as the
geometric mean of three separate experiments. Quantitative
culture results regarding the in vivo studies were presented as
the mean the standard deviation of the mean; comparisons
of the results were performed with analysis of variance on the
log-transformed data with Tukey-Kramer significant differ-
ence test. As specified previously, to strengthen the statistical
analysis, each animal received two graft specimens, so that 40
graft specimens were analyzed from each group. Significance
was accepted when the P value was .05 or less.
RESULTS
In vitro studies
According to the broth-microdilution method, vanco-
mycin hydrochloride showed the greatest potency against
the strains tested, with MICs of 0.25 mg/L and 0.50
mg/L for S epidermidis ATCC 12228 and S epidermidis
Se15-00, respectively. Interestingly, the two organisms
were similarly susceptible to temporin A that showed MICs
of 8 mg/L for both strains. Finally, the two strains showed
different susceptibility patterns for the betalactam antibiot-
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ics: S epidermidis ATCC 12228 was susceptible to oxacillin
sodium and cefazolin (MIC values, 0.5 and 2 mg/L, re-
spectively), and S epidermidis Se15-00 was resistant (MIC
values, 8 and 32 mg/L, respectively).
In vivo studies
S epidermidis ATCC 12228. None of the animals
included in the control group C0 had microbiologic evi-
dence of graft infection. On the contrary, all rats included
in the untreated control C1 showed evidence of graft infec-
tion, with quantitative culture results showing 1.9 107
5.1  106 CFU/cm2 graft.
Culture from the group that received temporin A–soaked
graft (TT) showed 3.4  10
3  7.1  102 CFU/cm2 graft,
and similar results were obtained from the groups that re-
ceived intraperitoneal cefazolin (TC) and vancomycin hydro-
chloride (TV) prophylaxis (5.9 10
3 4.7 102 CFU/cm2
graft, and 4.4  102  2.0  102 CFU/cm2 graft, respec-
tively). For the group that received temporin A–soaked graft
associate to intraperitoneal cefazolin (TT–C) the quantitative
graft cultures showed weak bacterial growth (2.5  101 
0.7  101 CFU/cm2 graft, respectively). Finally, the group
that received temporin A–soaked graft associate to periopera-
tive intraperitoneal vancomycin hydrochloride (TT–V) showed
no evidence of staphylococcal infection, with negative quan-
titative cultures (Fig 1).
S epidermidis Se15-00. Similar to the series concern-
ing MS strain, none of the animals included in the control
group C0 had microbiologic evidence of graft infection.
The rats included in the untreated control C1 showed
evidence of graft infection with quantitative culture of
3.9  107  1.2  107 CFU/cm2 graft. Culture from the
group that received temporin A–soaked graft (TT) and
intraperitoneal vancomycin hydrochloride (TV) prophy-
laxis showed significant results if compared with C1 (6.1
103  2.2  102 CFU/cm2 graft, and 5.9  102  2.3 
102 CFU/cm2 graft, respectively), and the group that
received intraperitoneal cefazolin prophylaxis (TC) showed
no statistically significant difference versus C1 with quanti-
tative culture of 6.7  107  7.9  106 CFU/cm2 graft.
For the group that received combined treatment, only the
group TT-V showed no evidence of staphylococcal growth,
and quantitative cultures from group TT-C showed bacte-
rial growth (3.0  103  0.7  103 CFU/cm2 graft) that
was significantly lower when compared with C1 (Fig 2).
DISCUSSION
Prosthetic vascular grafts are foreign bodies that can
harbor bacteria within their interstices. Most graft infec-
tions are thought to arise with contamination of the pros-
theses at the time of insertion. Contamination may occur
because of inadequate sterilization or breakdown in the
sterilization technique.1 In the clinical practice, strategies
for the prevention of infections are considered with respect
to the periods before, during, and after operation. Paren-
teral antibiotic prophylaxis has been shown to reduce the
incidence of wound and graft infection. Nevertheless, dur-
ing the last decades, resistance among clinical isolates
against currently available antimicrobial agents has
emerged at an alarming rate.22-24 The emergence of the
resistant organisms has stimulated the search for new bac-
tericidal agents, naturally occurring antimicrobial mole-
cules that may have clinial utility. The temporins are a
group of small, basic, and hydrophobic peptides that have
been isolated from the skin of the European red frog. They
show activity against both gram-positive and gram–nega-
tive bacteria and are found to be nontoxic to human red
blood cells.14-16,25 Particularly, our results show that the
activity of temporin A appears similar against both the MS
and the MR strain, which suggests that methicillin sodium
susceptibility is not related to the mechanism of action of
this peptide. Actually, although methicillin sodium, similar
to all betalactams, inhibits the bacterial peptidoglycan syn-
thesis, temporin A is thought to act with the formation of
ion channel or pores in the bacterial cytoplasmic mem-
brane.17 The essential property of temporins is their net
positive charge at neutral pH (usually 1 or 2) by virtue
of their possession of the basic aminoacids arginine or
lysine. The antibiotic activity of the temporins is deter-
mined by their mode of interaction with the bacterial
Fig 1. MS S epidermidis ATCC 12228: Quantitative microbio-
logic results of in vivo experiments.
Fig 2. MR S epidermidis 15-00: Quantitative microbiologic re-
sults of in vivo experiments.
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surface.14,25 Nevertheless, although the activity against
gram-negative rods is probably from their positively
charged residues that interact with the negatively charged
lipids of the outer bacterial membrane before damaging the
function of the cytoplasmic membrane, there is still little
information about the initial events that could explain the
activity of cationic compounds against gram-positive or-
ganisms. However, the site for the lethal action of these
molecules is the cytoplasmic membrane, where the associ-
ation of several molecules would form water-filled pores
that would serve as ion-conducting, anion-selective chan-
nels.14-16,25 In addition, recent reports have shown that the
peptides may act by triggering the activity of bacterial
murein hydrolases, resulting in damage or degradation of
the peptidoglycan and lysis of the cell.26-28 Finally, it has
been suggested that the lytic activity of temporins could be
not affected by the membrane composition of the target
organism, differing from other antimicrobial peptides. This
lack of selectivity of temporins may be related to the low
number of positive charges; binding to the outer mem-
brane could be the result of hydrophobic interaction.
Taken together, the results of this study showed that
the use of temporin A–soaked Dacron graft in vascular
surgery can result in significant bacterial growth inhibition
even if high concentrations of organisms are topically inoc-
ulated on the Dacron prostheses. Statistical analysis showed
that most of the antibiotic prophylactic treatments were
useful; nevertheless, only the combination between tem-
porin A–soaked graft and intraperitoneal vancomycin hy-
drochloride was able to completely inhibit the bacterial
growth for both staphylococcal strains.
It is notable that the surface of several synthetic mate-
rials used by surgeons, such as polyesters, are negatively
charged at pH 7 and that this property permits binding of
cationic molecules.29-31 In virtue of this binding, the reten-
tion of the biologically active molecules is not from passive
entrapment in the plastic tissue but reflects an ionic inter-
action between the anionic ligands and the cationic com-
pounds that allow a lasting antimicrobial effect.
REFERENCES
1. Von Eiff C, Heilmann C, Peters G. New aspects in the molecular basis
of polymer-associated infections due to staphylococci. Eur J Clin Mi-
crobiol Infect Dis 1999;18:853-6.
2. Barie PS. antibiotic-resistant gram-positive cocci: implications for sur-
gical practice. World J Surg 1998;22:118-26.
3. Henke PK, Bergamini TM, Rose SM, Richardson JD. Current opinion
in prosthetic vascular graft infection. Am Surg 1998;64:39-45.
4. Bergamini TM, Corpus RA Jr, Brittian KR, Peyton JC, Cheadle WG.
The natural history of bacterial biofilm graft infection. J Surg Res
1994;56:393-6.
5. Bergamini TM, Peyton JC, Cheadle WG. Prophylactic antibiotics pre-
vent bacterial biofilm graft infection. J Surg Res 1992;52:101-5.
6. Monzon M, Oteiza C, Leiva J, Amorena B. Synergy of different
antibiotic combinations in biofilms of Staphylococcus epidermidis. J
Antimicrob Chemother 2001;48:793-801.
7. Sardelic F, Ao PY, Taylor DA, Fletcher JP. Prophylaxis against Staphy-
lococcus epidermidis vascular graft infection with rifampicin-soaked, gel-
atin-sealed Dacron. Cardiovasc Surg 1996;4:389-92.
8. Giacometti A, Cirioni O, Ghiselli R, Goffi L, Mocchegiani F, Riva A, et
al. Polycationic peptides as prophylactic agents against methicillin-
susceptible and methicillin-resistant Staphylococcus epidermidis vascular
graft infection. Antimicrob Agents Chemother 2000;44:3306-9.
9. Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Preven-
tion of graft infection by use of prostheses bonded with a rifampin
collagen release system. J Vasc Surg 1991;14:521-4.
10. Cannon M. A family of wound healers. Nature 1987;328:478.
11. Bevins CL, Zasloff M. Peptides from frog skin. Annu Rev Biochem
1990;59:395-414.
12. Clark DP, Durell S, Maloy WL, Zasloff M. Ranalexin: a novel antimicrobial
peptide from bullfrog (Rana catasbeiana) skin, structurally related to the
bacterial antibiotic polymyxin. J Biol Chem 1994;269:10849-55.
13. Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, et al.
Purification and characterization of antimicrobial and vasorelaxant pep-
tides from skin extracts and skin secretions of the North American pig
frog Rana grylio. Regul Pept 2000;90:53-60.
14. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D,
et al. Structure-function relationships of temporins, small antimicrobial
peptides from amphibian skin. Eur J Biochem 2000;267:1447-54.
15. Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, et
al. Effects of temporins on molecular dynamics and membrane perme-
abilization in lipid vesicles. J Pept Res 2001;58:213-20.
16. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.
Temporins, antimicrobial peptides from the European red frog Rana
temporaria. Eur J Biochem 1996;242:788-92.
17. Harjunpaa I, Kuusela P, Smoluch MT, Silberring J, Lankinen H, Wade
D. Comparison of synthesis and antibacterial activity of temporin A.
FEBS Lett 1999;449:187-90.
18. Wade D, Silberring J, Soliymani R, Heikkinen S, Kilpelainen I, Lanki-
nen H, et al. Antibacterial activities of temporin A analogs. FEBS Lett
2000;479:6-9.
19. National Committee for Clinical Laboratory Standards. Approved stan-
dards M7-A3. Methods for dilution antimicrobial susceptibility tests for
bacteria that grow aerobically. Wayne (PA): National Committee for
Clinical Laboratory Standards; 1997.
20. Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Fortuna M, Caselli
F, et al. In vitro susceptibility tests for cationic peptides: comparison of
microbroth dilution methods for bacteria that grow aerobically. Anti-
microb Agents Chemother 2000;44:1694-6.
21. Bergamini TM, Corpus RA Jr, McCurry TM, Peyton JC, Brittian KR,
Cheadle WG. Immunosuppression augments growth of graft-adherent
Staphylococcus epidermidis. Arch Surg 1995;130:1345-50.
22. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging
resistance and need for alternative agents. Clin Infect Dis 1998;26:1182-7.
23. Biavasco F, Vignaroli C, Varaldo PE. Glycopeptide resistance in coagulase-
negative staphylococci. Eur J Clin Microbiol Infect Dis 2000;19:403-17.
24. McManus AT, Goodwin CW, Pruitt BA Jr. Observations on the risk of
resistance with the extended use of vancomycin. Arch Surg 1998;133:
1207-11.
25. Goraya J, Wang Y, Li Z, O’Flaherty M, Knoop FC, Platz JE, et al.
Peptides with antimicrobial activity from four different families isolated
from the skins of the North American frogs Rana luteiventris, Rana
berlandieri and Rana pipiens. Eur J Biochem 2000;267:894-900.
26. Jack RW, Tagg JR, Ray B. Bacteriocins of Gram-positive bacteria.
Microbiol Rev 1995;59:171-200.
27. Moore AJ, Beazley WD, Bibby MC, Devine DA. Antimicrobial activity
of cecropins. J Antimicrob Chemother 1996;37:1077-89.
28. Sahl HG, Jack RW, Bierbaum G. Biosynthesis and biological activities
of lantibiotics with unique post-translational modifications. Eur J Bio-
chem 1995;230:827-53.
29. Harvey RA, Alcid DV, Greco RS. Antibiotic bonding to polytetrafluo-
roethylene with tridodecylmethylammonium chloride. Surgery 1982;
92:504-12.
30. Phaneuf MD, Quist WC, Bide MJ, LoGerfo FW. Modification of the
polyethylene terephthalate (Dacron) via denier reduction: effects on
material tensile strength, weight, and protein binding capabilities.
J Appl Biomater 1995;6:289-99.
31. Hancock REW. Peptides antibiotics. Lancet 1997;349:418-22.
Submitted Mar 21, 2002; accepted May 28, 2002.
JOURNAL OF VASCULAR SURGERY
November 20021030 Ghiselli et al
